Stock Analysis

Here's What Analysts Are Forecasting For Aubay Société Anonyme (EPA:AUB) After Its Yearly Results

ENXTPA:AUB
Source: Shutterstock

The full-year results for Aubay Société Anonyme (EPA:AUB) were released last week, making it a good time to revisit its performance. Aubay Société Anonyme reported in line with analyst predictions, delivering revenues of €534m and statutory earnings per share of €2.54, suggesting the business is executing well and in line with its plan. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Check out our latest analysis for Aubay Société Anonyme

earnings-and-revenue-growth
ENXTPA:AUB Earnings and Revenue Growth March 24th 2024

Taking into account the latest results, the current consensus from Aubay Société Anonyme's four analysts is for revenues of €545.6m in 2024. This would reflect an okay 2.1% increase on its revenue over the past 12 months. Per-share earnings are expected to ascend 10% to €2.83. Before this earnings report, the analysts had been forecasting revenues of €545.6m and earnings per share (EPS) of €2.71 in 2024. So the consensus seems to have become somewhat more optimistic on Aubay Société Anonyme's earnings potential following these results.

There's been no major changes to the consensus price target of €48.58, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Aubay Société Anonyme, with the most bullish analyst valuing it at €53.00 and the most bearish at €45.30 per share. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Aubay Société Anonyme is an easy business to forecast or the the analysts are all using similar assumptions.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Aubay Société Anonyme's revenue growth is expected to slow, with the forecast 2.1% annualised growth rate until the end of 2024 being well below the historical 6.5% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 6.9% annually. Factoring in the forecast slowdown in growth, it seems obvious that Aubay Société Anonyme is also expected to grow slower than other industry participants.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Aubay Société Anonyme following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at €48.58, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Aubay Société Anonyme analysts - going out to 2026, and you can see them free on our platform here.

Before you take the next step you should know about the 1 warning sign for Aubay Société Anonyme that we have uncovered.

Valuation is complex, but we're helping make it simple.

Find out whether Aubay Société Anonyme is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.